Chronic Kidney Disease

@ckd_ce on Twitter

Disclosures

Faculty                                  Relationship Identified With:
Hans-Joachim Anders, M.D.Consultant: Bayer, AstraZeneca, GSK, Novartis, Janssen; Speaker Honorarium: Lilly, Vifor, Otsuka
Sophia AmbrusoConsultant: AstraZeneca
Christos Argyropoulos MD, PhD, FASNConsultant: Baxter Healthcare, Bayer
Roopen AryaSpeaker’s Bureau: Sanofi, Cardinal Health
Jonathan BarrattResearch Grants: Argenx, Calliditas Therapeutics, Chinook Therapeutics, Galapagos NV, GSK, Novartis, Travere Therapeutics; Medical/Scientific Advisor: Alnylam Pharmaceuticals, Argenx, Astellas Pharma, BioCryst Pharmaceuticals, Calliditas Therapeutics, Chinook Therapeutics, Dimerix, Galapagos NV, Novartis, Omeros, Travere Therapeutics, UCB, Vera Therapeutics, Visterra
Sheila Bermejo GarcíaReports honorarium for conferences, consulting fees, and advisory boards from AstraZeneca, Boehringer and Mundipharma
Snehal H. Bhatt, PharmDSpeaker’s Bureau: Janssen Global Services, LLC
Hannah BebaConsultant and Speaker: AstraZeneca, Sanofi, Novonordisk; Sponsorship for Conference and Consultant and Speaker: BI/Lilly
Clara García CarroTravel and congress fees support from AstraZeneca, Esteve, NovoNordisk, Boehringer Ingelheim Lilly, Astellas, Otsuka, Novartis, Astellas, and Baxter; Scientific lectures, advisory boards and scientific committees organized by AstraZeneca, Boehringer Ingelheim Lilly, Mundipharma, Esteve and NovoNordisk
Dr. Fouad T. ChebibUnrestricted research grant: Otsuka Pharmaceuticals; PI of ongoing clinical study: Natera
Claire DaviesSpeaker: NovoNordisk, CMM, Astra Zeneca, CareFlow Medicines Management, Diabetes Professional Care, NAPP; Advisor: MTech Access, Roche; Author: Green Light Pharmacy
Tejas DesaiNothing to disclose
Kevin Fernando, MD  Consultant/Advisor: AstraZeneca Pharmaceuticals; Bayer AG; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Eli Lilly and Company; MSD Pharmaceuticals; NAPP Pharmaceuticals Limited; Novo Nordisk A/S; Sanofi Speaker’s Bureau: AstraZeneca Pharmaceuticals; Bayer AG; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Eli Lilly and Company; MSD Pharmaceuticals; NAPP Pharmaceuticals Limited; Novo Nordisk A/S; Sanofi; Daiichi Sankyo, Amgen & Amarin
Ines FonsecaSpeaker, conference support: Novo Nordisk; Conference support: Lilly; Speaker: AstraZeneca
Dominique Guerrot, MD, PhDNothing to disclose
Tess HarrisNothing to disclose
Will Herrington, MA, MBBS, MD, FRCPPersonal fellowship and institutional grant funding: Medical Research UK and Kidney Research UK.
Research support: Boehringer Ingelheim and Lilly.
I follow a departmental policy to decline any honoraria from the pharmaceutical or food industry.
Dr. Patrick Holmes MB BS, MSc, DipTher, MRCGPConsultant: AstraZeneca, NovoNordisk, Eli Lilly, Abbot; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim, NovoNordisk, Eli Lilly; Research Grant Recipient: NovoNordisk, Roche
Edgar V. LermaSpeaker’s Bureau: AstraZeneca; Bayer; Otsuka
Consultant: Vifor; Otsuka; Bayer
Hector MadariagaNothing to disclose
Ahmad MasriResearch Grants: Pfizer, Akcea, Ionis, Ultromics; Honoraria: Pfizer, Alnylam, Eidos, Akcea, Ionis, Cytokinetics, BMS; Consultant: Attralus, Tenaya, Ionis
Taher Modarressi, MDSpeakers’ Bureau: AstraZeneca
Dr Ahmed Mohsen, MD, MSc.Nothing to disclose
Naveed SattarConsulting/speaker honoraria: Abbott Laboratories, Afimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Janssen, MSD, Novartis, Novo Nordisk, Pfizer, Roche Diagnostics, Sanofi; Grants: AstraZeneca, Boehringer Ingelheim, Novartis, Roche Diagnostics 
Dr Sourabh SharmaNothing to disclose
Natalie Staplin, PhDResearch funding paid to institution for EMPA-KIDNEY trial: Boehringer Ingleheim; Eli Lilly and Company. Research funding paid to institution ASCEND-PLUS trial: Novo Nordisk.
Dr. Amar PuttannaSpeaker’s Bureau: Novo Nordisk, Lilly-Boehringer Ingelheim, Sanofi, Daiichi- Sankyo, AstraZeneca; Consulting: Sanofi
Richard PratleyGrants from Hanmi Pharmaceutical Co., Janssen; Consulting, Speak Fees from Merck; Grants, Speaker Fees and Consulting Fees from Novo Nordisk; Consulting Fees from Pfizer; Grants from Poxel SA; Grants and Consulting Fees from Sanofi; Consulting Fees From Scohia Pharma Inc.; Consulting Fees From Sun Pharmaceutical Industries (All honoraria directed toward a non-profit which supports education and research.)
Brian Rifkin, MDNothing to disclose
Carlo Nemesio Trinidad, MD, FPCP, FPSNSpeaker: AstraZeneca; Corbridge Philippines; Otsuka; Sanofi
Didem Turgut MD, MScNothing to disclose

All relevant financial relationships with ineligible companies for this educational content have been mitigated.